Thomas J. Schall
2014
In 2014, Thomas J. Schall earned a total compensation of $2.6M as President and Chief Executive Officer at ChemoCentryx, a 14% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $247,500 |
|---|---|
| Option Awards | $1,837,145 |
| Salary | $550,000 |
| Other | $1,290 |
| Total | $2,635,935 |
Schall received $1.8M in option awards, accounting for 70% of the total pay in 2014.
Schall also received $247.5K in non-equity incentive plan, $550K in salary and $1.3K in other compensation.
Rankings
In 2014, Thomas J. Schall's compensation ranked 3,455th out of 13,032 executives tracked by ExecPay. In other words, Schall earned more than 73.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,455 out of 13,032 | 74th |
Division Manufacturing | 1,219 out of 4,966 | 76th |
Major group Chemicals And Allied Products | 395 out of 1,686 | 77th |
Industry group Drugs | 307 out of 1,365 | 78th |
Industry Pharmaceutical Preparations | 250 out of 1,043 | 76th |
Source: SEC filing on April 11, 2016.
Schall's colleagues
We found two more compensation records of executives who worked with Thomas J. Schall at ChemoCentryx in 2014.